A 56-year-old man with T2D and symptomatic PAD asks about glucose management to reduce MACE. Which combination has outcome data in PAD per guideline?...

Question

A 56-year-old man with T2D and symptomatic PAD asks about glucose management to reduce MACE. Which combination has outcome data in PAD per guideline?

Accepted Answer

SGLT2 inhibitor and GLP‑1 receptor agonist

Answer

DPP‑4 inhibitor and sulfonylurea

Answer

Insulin and thiazolidinedione

Answer

Meglitinide and alpha-glucosidase inhibitor

Answer

No agent reduces MACE in PAD

us-usmle-step-2 MCQ (SBA): PAD-Diabetes Agents with CV Benefit